Founded in New York City, Oova aims to simplify women's fertility journeys through innovative technology. The company's core mission is to help women achieve their fertility goals without disrupting their busy lifestyles. Oova offers at-home hormone tests that measure luteinizing hormone (LH), estrone-3-glucuronide (E3G), and pregnanediol glucuronide (PdG) levels. These tests are paired with an AI-powered smartphone app that provides daily quantitative hormone levels to track and predict ovulation. Oova focuses on women seeking to better understand their ovulation patterns and fertility health.
Notable affiliated people include the founders and key investors who have supported Oova's mission to revolutionize fertility tracking. The company has achieved significant milestones, including the development of its proprietary hormone tests and AI-driven app, which have garnered positive feedback from users. Oova's impact lies in its ability to provide women with accurate, real-time insights into their fertility health, empowering them to make informed decisions about their reproductive journey.
